Philippe Gaulard

9PUBLICATIONS
168CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursTumour immunologyGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 04, 2025
Brentuximab vedotin addition to gemcitabine in relapsed or refractory peripheral T-cell lymphoma: a LYSA phase 2 study.

Olivier Tournilhac, Kamal Bouabdallah, Solène Lecolant

|Sep 13, 2024
Long-Term Follow-Up of the Prospective Randomized AATT Study (Autologous or Allogeneic Transplantation in Patients With Peripheral T-Cell Lymphoma).

Olivier Tournilhac, Bettina Altmann, Birte Friedrichs

|Jul 17, 2024
Lymphoma Classifications, How to Develop a Future Unified Taxonomy.

Elias Campo, Daan Dierickx, Stefan Dirnhofer

|May 10, 2024
A practical approach to the modern diagnosis and classification of T- and NK-cell lymphomas.

Laurence de Leval, Philippe Gaulard, Ahmet Dogan

|Apr 24, 2024
Comprehensive Genetic Profiling Reveals Frequent Alterations of Driver Genes on the X Chromosome in Extranodal NK/T-cell Lymphoma.

Yuta Ito, Amira Marouf, Yasunori Kogure

|Feb 16, 2024
Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP Trial.

Vincent Camus, Catherine Thieblemont, Philippe Gaulard

Pageof 2

Frequent Collaborators

7 joint publications

Laurence L de Leval

4 joint publications

Emmanuel Bachy

4 joint publications

Gandhi Laurent Damaj

3 joint publications

Vincent Camus